肿瘤甲基化标志物研究进展&未来展望 | 《中国恶性肿瘤学科发展报告（2023）》

【主编】

邢金良    空军军医大学

聂勇战    空军军医大学附属西京医院

曾木圣    中山大学肿瘤防治中心

谢晓冬    北部战区总医院

【副主编】

陈奎生    郑州大学第一附属医院

袁响林    华中科技大学同济医学院附属同济医院

王书奎    南京医科大学附属南京医院/南京市第一医院

宋现让    山东第一医科大学附属肿瘤医院

黄灿华    四川大学华西基础医学与法医学院

张媛媛    四川大学华西基础医学与法医学院

于文强    复旦大学生物医学研究院

吕   斌    南华大学

孙世权    西安交通大学公共卫生学院

缪洪明    陆军军医大学

杨   帆    重庆大学附属中心医院

李   伟    复旦大学生物医学研究院

葛圣阳    复旦大学生物医学研究院

谢   丽    山东第一医科大学附属肿瘤医院

黄启超    空军军医大学

席文文    南华大学

【编委】

葛圣阳    复旦大学生物医学研究院

吕艺蓁    西安交通大学公共卫生学院

孙晓东    四川大学华西基础医学与法医学院

周昕萌    四川大学华西基础医学与法医学院

廖青青    四川大学华西基础医学与法医学院

谢   娜    四川大学华西基础医学与法医学院

陈   瑶    重庆大学附属中心医院

黎   莉    重庆大学附属中心医院

冯天琳    重庆大学附属中心医院

郭   旭    空军军医大学

徐治洪    空军军医大学

[1] SUN Y，STRANSKY S，AGUILAN J，et al.High throughput and low bias DNA methylation and hydroxymethylation analysis by direct injection mass spectrometry［J］.Anal Chim Acta，2021，1180：338880.

[2] MERKEL A，FERNáNDEZ⁃CALLEJO M，CASALS E，et al.gemBS：high throughput processing for DNA methylation data from bisulfite sequencing［J］.Bioinformatics，2019，35（5）：737⁃742.

[3] HAN Z W，MA F，ZHANG C Y.Methylation ⁃ sensitive transcription ⁃enhanced single molecule biosensing of DNA methylation in cancer cells and tissues［J］.Anal Chim Acta，2023，1251：340996.

[4] HOSSEINI M，LOTFI ⁃ SHAHREZA M，NIKPOUR P. Integrative analysis of DNA methylation and gene expression through machine learning identifies stomach cancer diagnostic and prognostic bio⁃ markers［J］.J Cell Mol Med，2023，27（5）：714⁃726.

[5] XU W，XU M，WANG L，et al.Integrative analysis of DNA methylation and gene expression identified cervical cancer ⁃ specific diagnostic biomarkers［J］.Signal Transduct Target Ther，2019，4：55.

[6] OOKI A，MALEKI Z，TSAY J J，et al.A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non ⁃ Small Cell Lung Cancer and Serum DNA［J］.Clin Cancer Res，2017 23（22）：7141⁃7152.

[7] IBRAHIM J ，PEETERS M ，VAN CAMP G ，et al. Methylation biomarkers for early cancer detection and diagnosis：Current and future perspectives［J］.Eur J Cancer，2023，178：91⁃113.

[8] HONG S，LIN B，XU M，et al.Cell⁃free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma［J］.EBioMedicine，2023，90：104497.

[9] XIE Y，LI P，SUN D，et al.DNA Methylation ⁃Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detec⁃tion of Colorectal Cancer［J］.Cancer Res，2023，83（21）：3636⁃3649.

[10] LI F，ZHENG Z，CHEN W，et al.Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms［J］.Drug Resist Updat，2023，68：100938.

[11] SSBIZZERA M，DESCOTES F，ARBER T，et al.Bladder cancer detection in patients with neurogenic bladder：are cystoscopy and cytology effective，and are biomarkers pertinent as future diagnostic tools? A scoping review［J］.World J Urol，2022，40（8）：1897⁃1913

[12] WEVER B M M，VAN DEN HELDER R，VAN SPLUNTER A P，et al.DNA methylation testing for endometrial cancer detection in urine，cervicovaginal self ⁃ samples and cervical scrapes［J］. Int JCancer，2023，153（2）：341⁃351.

[13] BAKKUM ⁃GAMEZ J N，SHERMAN M E，SLETTEDAHL S W，et al.Detection of endometrial cancer using tampon ⁃ based collection and methylated DNA markers［J］.Gynecol Oncol，2023，174：11⁃20

[14] LI J，LI Y，LI W，et al.Guide Positioning Sequencing identifies aberrant DNA methylation patterns that alter cell identity and tumor ⁃immune surveillance networks［J］.Genome Res，2019，29（2）：270⁃280.

[15] DONG S，LI W，WANG L，et al.Histone⁃Related Genes Are Hyper⁃ methylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan ⁃Cancer Biomarker［J］.Cancer Res，2019，79（24）：6101⁃6112.

[16] DONG S，LU Q，XU P，et al.Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening［J］.Clin Transl Med，2021，11（6）：e457.

[17] CHENG J，SWARUP N，LI F，et al.Distinct Features of Plasma Ultrashort Single⁃Stranded Cell⁃Free DNA as Biomarkers for Lung Cancer Detection［J］.Clin Chem，2023，69（11）：1270⁃1282.

[18] SAURA C，ORTIZ C，MATITO J，et al.Early ⁃ Stage Breast Cancer Detection in Breast Milk［J］.Cancer Discov，2023，13（10）：2180⁃2191.

[19] STOECKLEIN N H，FLUEGEN G，GUGLIELMI R，et al.Ultra⁃sen⁃sitive CTC ⁃ based liquid biopsy for pancreatic cancer enabled by large blood volume analysis［J］.Mol Cancer，2023，22（1）：181.

[20] KO S Y，LEE W，WEIGERT M，et al.The glycoprotein CD147 de⁃ fines miRNA ⁃enriched extracellular vesicles that derive from can⁃cer cells［J］.J Extracell Vesicles，2023，12（4）：e12318.

[21] ZHAI C，XIE F，XU J，et al.Correlation between membrane pro⁃teins and sizes of extracellular vesicles and particles：A potential signature for cancer diagnosis［J］. J Extracell Vesicles，2023，12（12）：e12391.

[22] RUI T，WANG K，XIANG A，et al.Serum Exosome⁃Derived piRNAs Could Be Promising Biomarkers for HCC Diagnosis［J］.Int J Nano⁃medicine，2023，18：1989⁃2001.

[23] CARBONELL C，FRIGOLA J，PARDO N，et al.Dynamic changes in circulating tumor DNA assessed by shallow whole⁃genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC［J］.Mol Oncol，2023，17（5）：779⁃791.

[24] XUE K H，JIANG Y F，BAI J Y，et al.Melatonin suppresses Akt/mTOR/S6K activity，induces cell apoptosis，and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect［J］.Redox Rep，2023，28（1）：2251234.

[25] LI Y，TANG S，SHI X，et al.Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy⁃resistant pancreatic cancer［J］.Cell Rep Med，2023，4（9）：101162.

[26] YUAN T，ZHOU T，QIAN M，et al.SDHA/B reduction promotes hepatocellular carcinoma by facilitating the deNEDDylation of cullin1 and stabilizing YAP/TAZ［J］.Hepatology，2023，78（1）：103⁃119.

[27] MILLER J J，GONZALEZ CASTRO L N，MCBRAYER S，et al.Isocitrate dehydrogenase（IDH）mutant gliomas：A Society for Neuro⁃Oncology（SNO）consensus review on diagnosis，management，and future directions［J］.Neuro Oncol，2023，25（1）：4⁃25.

[28] LYU J，LIU Y，GONG L，et al.Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance［J］.Cancer Discov，2023，13（1）：170⁃193.

[29] BROWN K，JENKINS L M M，CROOKS D R，et al.Targeting mutant p53⁃R248W reactivates WT p53 function and alters the onco⁃metabolic profile［J］.Front Oncol，2023，12：1094210.

[30] MALHOTRA S，MIRAS M C M，PAPPOLLA A，et al.Liquid Biopsy in Neurological Diseases［J］.Cells，2023，12（14）：1911.

[31] DE RASMO D，CORMIO A，CORMIO G，et al.Ovarian Cancer：A Landscape of Mitochondria with Emphasis on Mitochondrial Dynamics［J］.Int J Mol Sci，2023，24（2）：1224.

[32] CHEN X，WEI C，HUANG L，et al.Non⁃coding RNAs regulate mito⁃chondrial dynamics in the development of gastric cancer［J］.Front Mol Biosci，2023，10：1107651.

[33] FONTANA F，ANSELMI M，LIMONTA P.Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer［J］.Cancers（Basel），2023，15（4）：1192.

[34] LI S，HAN S，ZHANG Q，et al.FUNDC2 promotes liver tumorigenesis by inhibiting MFN1⁃mediated mitochondrial fusion［J］.Nat Commun，2022，13（1）：3486.

[35] WU J，DENG Z，ZHU Y，et al.Overexpression of miR⁃431⁃5p impairs mitochondrial function and induces apoptosis in gastric cancer cells via the Bax/Bcl⁃2/caspase3 pathway［J］.Nan Fang Yi Ke Da Xue Xue Bao，2023，43（4）：537⁃543.

[36] MENG H W，SHEN Z B，MENG X S，et al.Novel flavonoid 1，3，4⁃oxadiazole derivatives ameliorate MPTP ⁃ induced Parkinson's dis⁃ease via Nrf2 / NF ⁃ κB signaling pathway［J］. Bioorg Chem，2023，138：106654.

[37] HEISER C N，SIMMONS A J，REVETTA F，et al.Molecular cartog⁃raphy uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors［J］.Cell，2023，186（25）：5620⁃5637.

[38] LIN J R，WANG S，COY S，et al.Multiplexed 3D atlas of state tran⁃sitions and immune interaction in colorectal cancer［J］.Cell，2023，186（2）：363⁃381.

[39] MARUSYK A，ALMENDRO V，POLYAK K.Intra⁃tumour heteroge⁃neity：a looking glass for cancer?［J］.Nat Rev Cancer，2012，12（5）：323⁃334.

[40] EDITORIAL.A focus on single⁃cell omics［J］.Nat Rev Genet，2023，24（8）：485.

[41] ZENG Q，MOUSA M，NADUKKANDY A S，et al.Understanding tumour endothelial cell heterogeneity and function from single⁃cell omics［J］.Nat Rev Cancer，2023，23（8）：544⁃564.

[42] SO W V，DEJARDIN D，ROSSMANN E，et al.Predictive biomarkers for PD⁃1/PD⁃L1 checkpoint inhibitor response in NSCLC：an analysis of clinical trial and real⁃world data［J］.J Immunother Cancer，2023，11（2）：e006464.

[43] ZHANG R，WANG J，DU Y，et al.CDK5 destabilizes PD ⁃ L1 via chaperon⁃mediated autophagy to control cancer immune surveillance in hepatocellular carcinoma［J］.J Immunother Cancer，2023，11（11）：e007529.

[44] DEUTSCH J S，LAI J，SCHENK K M，et al.Immune microenvironment of basal cell carcinoma and tumor regression following combined PD⁃1/LAG⁃3 blockade［J］.J Immunother Cancer，2023，11（12）：e007463.

[45] SABERZADEH⁃ARDESTANI B，GRAHAM R P，MCMAHON S，et al.Immune Marker Spatial Distribution and Clinical Outcome after PD⁃1 Blockade in Mismatch Repair⁃deficient，Advanced Colorectal Carcinomas［J］.Clin Cancer Res，2023，29（20）：4268⁃4277.

[46] GONZALEZ⁃MUNOZ T，DI GIANNATALE A，GARCIA⁃SILVA S，et al.Endoglin，a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis［J］.Clin Cancer Res，2023，29（18）：3744⁃3758.

[47] ZHU Q，XU H，HUANG L，et al. Identification and detection of plasma extracellular vesicles ⁃ derived biomarkers for esophageal squamous cell carcinoma diagnosis［J］.Biosens Bioelectron，2023，225：115088.

[48] LIEN H E，BERG H F，HALLE M K，et al.Single⁃cell profiling of low ⁃ stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease［J］.EBioMedicine，2023，92：104595.

[49] MARTIN A，EPIFANO C，VILAPLANA⁃MARTI B，et al.Mitochondrial RNA methyltransferase TRMT61B is a new，potential biomarker and therapeutic target for highly aneuploid cancers［J］.Cell Death Differ，2023，30（1）：37⁃53.

[50] TAYLOR M S，WU C，FRIDY P C，et al.Ultrasensitive Detection of Circulating LINE⁃1 ORF1p as a Specific Multicancer Biomarker［J］.Cancer Discov，2023，13（12）：2532⁃2547.

[51] YU H，SHI T，YAO L，et al. Elevated nuclear PIGL disrupts the cMyc/BRD4 axis and improves PD⁃1 blockade therapy by dampening tumor immune evasion［J］.Cell Mol Immunol，2023，20（8）：867⁃880.

[52] YU Q，FU W，FU Y，et al.BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours［J］.Mol Cancer，2023，22（1）：143.

[53] ZHU X，SU Q，XIE H，et al.SIRT1 deacetylates WEE1 and sensitizes cancer cells to WEE1 inhibition［J］.Nat Chem Biol，2023，19（5）：585⁃595.

[54] PLAZA A，PASTOR⁃FERNANDEZ A，LOPEZ⁃ACEITUNO J L，et al. p21 is necessary for the beneficial effects of fasting during chemotherapy［J］.Cancer Commun（Lond），2023，43（1）：164⁃168.

[55] ZHENG X，LUO Y，XIONG Y，et al.Tumor cell⁃intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1⁃STAT1 pathway［J］.J Immunother Cancer，2023，11（12）：e007678.

[56] SON J A，WEON J H，BAEK G O，et al.Circulating small extracellular vesicle⁃derived splicing factor 3b subunit 4 as a non⁃invasive diagnostic biomarker of early hepatocellular carcinoma［J］.J Exp Clin Cancer Res，2023，42（1）：288.

[57] BARTH D A，MOIK F，STEINLECHNER S，et al.Early kinetics of C reactive protein for cancer⁃agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors：a multicenter cohort study［J］.J Immunother Cancer，2023，11（12）：

e007765.

[58] DANTAS E，MURTHY A，AHMED T，et al.TIMP1 is an early biomarker for detection and prognosis of lung cancer［J］. Clin Transl Med，2023，13（10）：e1391.

[59] HUBERS C，ABDUL PARI A A，GRIESHOBER D，et al.Primary tumor ⁃ derived systemic nANGPTL4 inhibits metastasis［J］.J Exp Med，2023，220（1）：e20202595.

[60] JIANG C，KUMAR A，YU Z，et al.Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor［J］.J Clin Invest，2023，133（12）：e168227.

[61] MUNSON P V，ADAMIK J，HARTMANN F J，et al.Polyunsaturated Fatty Acid⁃Bound alpha⁃Fetoprotein Promotes Immune Suppression by Altering Human Dendritic Cell Metabolism［J］. Cancer Res，2023，83（9）：1543⁃1557.

[62] NISMAN B，OLEINIKOV K，NECHUSHTAN H，et al. Plasma Progastrin⁃Releasing Peptide and Chromogranin A Assays for Diag⁃nosing and Monitoring Lung Well ⁃ Differentiated Neuroendocrine Tumors：A Brief Report［J］.J Thorac Oncol，2023，18（3）：369⁃376.

[63] SHI J，ZHOU M，ZHOU X，et al.Multi⁃omics and case⁃control analyses identify immunoglobulin M as a tumour ⁃ derived serum biomarker of ocular adnexal extranodal marginal zone lymphoma［J］. Clin Transl Med，2023，13（5）：e1259.

[64] BIAN X，JIANG H，MENG Y，et al.Regulation of gene expression by glycolytic and gluconeogenic enzymes［J］. Trends Cell Biol，2022，32（9）：786⁃799.

[65] WU D，LI Z，ZHANG Y，et al.Proline uptake promotes activation of lymphoid tissue inducer cells to maintain gut homeostasis［J］.Nat Metab，2023，5（11）：1953⁃1968.

[66] XUE Y，LU F，CHANG Z，et al.Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade［J］.Nat Commun，2023，14（1）：4758.

[67] DE FALCO P，LAZZARINO G，FELICE F，et al.Hindering NAT8L expression in hepatocellular carcinoma increases cytosolic aspartate delivery that fosters pentose phosphate pathway and purine biosynthesis promoting cell proliferation［J］.Redox Biol，2023，59：102585.

[68] HU J，ZHANG Z，HU H，et al.LRH⁃1 activation alleviates diabetes⁃induced podocyte injury by promoting GLS2⁃mediated glutaminolysis［J］.Cell Prolif，2023，56（11）：e13479.

[69] YANG S，JIN S，XIAN H，et al.Metabolic enzyme UAP1 mediates IRF3 pyrophosphorylation to facilitate innate immune response［J］.Mol Cell，2023，83（2）：298⁃313.

[70] ZOU S，QIN B，YANG Z，et al.CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer［J］.Cancer Res，2023，83（3）：414⁃427.

[71] NICASTRO R，BROHEE L，ALBA J，et al.Malonyl⁃CoA is a conserved endogenous ATP⁃competitive mTORC1 inhibitor［J］.Nat Cell Biol，2023，25（9）：1303⁃1318.

[72] TANG T，HUANG X，LU M，et al.Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor⁃autonomous and ⁃autocrine manner［J］.Nat Commun，2023，14（1）：3364.

[73] CHEU J W，CHIU D K，KWAN K K，et al.Hypoxia⁃inducible factor orchestrates adenosine metabolism to promote liver cancer develop⁃ment［J］.Sci Adv，2023，9（18）：eade5111.

[74] KOWASH R R，AKBAY E A.Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer［J］.Front Immunol，2023，14:1130358.